<i>PIK3CA</i> Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy

<i>PIK3CA</i> Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy

Background: The prognostic relevance of the <i>PIK3CA</i> mutation together with PD-L1, c-Met, and mismatch repair deficiency (dMMR) have not been fully investigated in Asian women with breast cancer (BC) who have undergone postoperative adjuvant chemotherapy. Methods: We analyzed <i&...

Full description

Bibliographic Details
Main Authors: Yoon Ah Cho, Seung Yeon Ko, Yong Joon Suh, Sanghwa Kim, Jung Ho Park, Hye-Rim Park, Jinwon Seo, Hyo Geun Choi, Ho Suk Kang, Hyun Lim, Ha Young Park, Mi Jung Kwon
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Current Oncology
Subjects:
<i>PIK3CA</i> mutation
adjuvant chemotherapy
breast cancer
invasive ductal carcinoma
c-Met
PD-L1
Online Access:https://www.mdpi.com/1718-7729/29/5/236

Internet

https://www.mdpi.com/1718-7729/29/5/236

Similar Items